BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 1340770)

  • 1. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Beg AA; Ruben SM; Scheinman RI; Haskill S; Rosen CA; Baldwin AS
    Genes Dev; 1992 Oct; 6(10):1899-913. PubMed ID: 1340770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins.
    Léveillard T; Verma IM
    Gene Expr; 1993; 3(2):135-50. PubMed ID: 8268718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
    Miyamoto S; Seufzer BJ; Shumway SD
    Mol Cell Biol; 1998 Jan; 18(1):19-29. PubMed ID: 9418849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways.
    Espinosa L; Inglés-Esteve J; Robert-Moreno A; Bigas A
    Mol Biol Cell; 2003 Feb; 14(2):491-502. PubMed ID: 12589049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short segment within the cytoplasmic domain of the neural cell adhesion molecule (N-CAM) is essential for N-CAM-induced NF-kappa B activity in astrocytes.
    Little EB; Crossin KL; Krushel LA; Edelman GM; Cunningham BA
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2238-43. PubMed ID: 11226223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial delivery of therapeutic proteins to the nuclei of cancer cells.
    Bloom SMK; O'Hare N; Forbes NS
    Biotechnol Bioeng; 2023 May; 120(5):1437-1448. PubMed ID: 36710503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4.
    Fagerlund R; Kinnunen L; Köhler M; Julkunen I; Melén K
    J Biol Chem; 2005 Apr; 280(16):15942-51. PubMed ID: 15677444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSK3 switches cell fate: from stress-induced senescence to malignant progression.
    Huna A; Flaman JM; Lodillinsky C; Zhu K; Makulyte G; Pakulska V; Coute Y; Ruisseaux C; Saintigny P; Hernandez-Vargas H; Defossez PA; Boissan M; Martin N; Bernard D
    J Exp Clin Cancer Res; 2023 Nov; 42(1):318. PubMed ID: 38008756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-dependent protein kinase catalytic subunit binds to the transactivation domain 1 of NF-κB p65.
    Hasegawa Y; Asada S
    Biochem Biophys Rep; 2023 Sep; 35():101538. PubMed ID: 37674974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on inhibition of the Aβ
    Jiang S; Yu LJ; Yang H; Jin Y; Chen J; Zhang JH; Liu Y; Xu Y
    Arch Med Sci; 2023; 19(4):1136-1144. PubMed ID: 37560736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lost and Found: The Family of NF-κB Inhibitors Is Larger than Assumed in Salmonid Fish.
    van Muilekom DR; Collet B; Rebl H; Zlatina K; Sarais F; Goldammer T; Rebl A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas.
    Bredel M; Espinosa L; Kim H; Scholtens DM; McElroy JP; Rajbhandari R; Meng W; Kollmeyer TM; Malta TM; Quezada MA; Harsh GR; Lobo-Jarne T; Solé L; Merati A; Nagaraja S; Nair S; White JJ; Thudi NK; Fleming JL; Webb A; Natsume A; Ogawa S; Weber RG; Bertran J; Haque SJ; Hentschel B; Miller CR; Furnari FB; Chan TA; Grosu AL; Weller M; Barnholtz-Sloan JS; Monje M; Noushmehr H; Jenkins RB; Rogers CL; MacDonald DR; Pugh SL; Chakravarti A
    Cell Rep Med; 2023 Jun; 4(6):101082. PubMed ID: 37343523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current progress on innate immune evasion mediated by N
    Wen S; Li X; Lv X; Liu K; Ren J; Zhai J; Song Y
    Front Immunol; 2023; 14():1136051. PubMed ID: 37090696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling.
    Lee FFY; Alper S
    Front Immunol; 2022; 13():1023567. PubMed ID: 36531997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid.
    Ahmad S; Bhanu P; Kumar J; Pathak RK; Mallick D; Uttarkar A; Niranjan V; Mishra V
    Bioinformation; 2022; 18(3):170-179. PubMed ID: 36518123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins.
    Lu Y; Michel HA; Wang PH; Smith GL
    Front Microbiol; 2022; 13():1027015. PubMed ID: 36478862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1β triggers matrix metalloprotease-3 expression through p65/RelA activation in melanoma cells.
    Nunomura J; Nakano R; Naruke A; Suwabe Y; Nakano M; Yachiku N; Kuji M; Sugimura M; Namba S; Kitanaka T; Kitanaka N; Sugiya H; Nakayama T
    PLoS One; 2022; 17(11):e0278220. PubMed ID: 36445856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GJD Modulates Cardiac/Vascular Inflammation and Decreases Blood Pressure in Hypertensive Rats.
    Mohammed SAD; Liu H; Baldi S; Chen P; Lu F; Liu S
    Mediators Inflamm; 2022; 2022():7345116. PubMed ID: 36164390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to Inhibit Nuclear Factor-Kappa B Signaling: Lessons from Poxviruses.
    Reus JB; Rex EA; Gammon DB
    Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CF-PPiD technology based on cell-free protein array and proximity biotinylation enzyme for in vitro direct interactome analysis.
    Sugiyama S; Yamada K; Denda M; Yamanaka S; Ozawa S; Morishita R; Sawasaki T
    Sci Rep; 2022 Jun; 12(1):10592. PubMed ID: 35732899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.